Details for New Drug Application (NDA): 215719
✉ Email this page to a colleague
The generic ingredient in LOTEPREDNOL ETABONATE is loteprednol etabonate. There are ten drug master file entries for this compound. Eight suppliers are listed for this compound. Additional details are available on the loteprednol etabonate profile page.
Summary for 215719
Tradename: | LOTEPREDNOL ETABONATE |
Applicant: | Lupin Ltd |
Ingredient: | loteprednol etabonate |
Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 215719
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | SUSPENSION/DROPS;OPHTHALMIC | Strength | 0.5% | ||||
Approval Date: | Apr 24, 2024 | TE: | AB | RLD: | No |
Complete Access Available with Subscription